[Turku PET Centre] [PET data analysis] [Main page]

References to PET modelling

Budinger TF, Huesman RH, Knittel B, Friedland RP, Derenzo SE (1985): Physiological modeling of dynamic measurements of metabolism using positron emission tomography. In: The Metabolism of the Human Brain Studied with Positron Emission Tomography. (Eds: Greitz T et al.) Raven Press, New York, 165-183.

Cunningham VJ, Rabiner EA, Matthews JC, Gunn RN, Zamuner S, Gee AD. Kinetic analysis of neuroreceptor binding using PET. Int Congress Series 2004; 1265: 12-24.

van den Hoff J. Principles of quantitative positron emission tomography. Amino Acids 2005; 29(4): 341-353.

Huang SC, Phelps ME (1986): Principles of tracer kinetic modeling in positron emission tomography and autoradiography. In: Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. (Eds: Phelps,M; Mazziotta,J; Schelbert,H) Raven Press, New York, 287-346.

Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J. Nucl. Med. 2001; 42:755-763.

Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4: 153-158.

Lammertsma AA. Radioligand studies: imaging and quantitative analysis. Eur. Neuropsychopharmacol. 2002; 12: 513-516.

Laruelle M. Modelling: when and why? Eur. J. Nucl. Med. 1999; 26, 571-572.

Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 2000; 20: 423-451.

Laruelle M, Slifstein M, Huang Y. Positron emission tomography: imaging and quantification of neurotransporter availability. Methods 2002; 27:287-299.

Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl. Med. Biol. 2000; 27:661-670.

Meikle SR, Eberl S, Iida H. Instrumentation and methodology for quantitative pre-clinical imaging studies. Curr. Pharm. Des. 2001; 7(18): 1945-1966.

Passchier J, Gee A, Willemsen A, Vaalburg W, van Waarde A. Measured drug-related receptor occupancy with positron emission tomography. Methods 2002; 27:278-286.

Schmidt KC, Turkheimer FE. Kinetic modeling in positron emission tomography. Q. J. Nucl. Med. 2002; 46:70-85.

Slifstein M, Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol. 2001; 28:595-608.

Turkheimer F, Sokoloff L, Bertoldo A, Lucignani G, Reivich M, Jaggi JL, Schmidt K. Estimation of component and parameter distributions in spectral analysis. J. Cereb. Blood Flow Metabol. 1998; 18: 1211-1222.

Turkheimer FE, Hinz R, Cunningham VJ. On the undecidability among kinetic models: from model selection to model averaging. J. Cereb. Blood Flow Metab. 2003; 23: 490-498.

Watabe H, Ikoma Y, Kimura Y, Naganawa M, Shidahara M. PET kinetic analysis - compartmental model. Ann Nucl Med. 2006; 20(9): 583-588.

---

Researchers in Turku PET Centre: ask Vesa Oikonen for copies.

---